TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
1-Year Return
35.44%
This Quarter Return
-0.92%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$312M
AUM Growth
+$42.9M
(+16%)
Cap. Flow
+$55.7M
Cap. Flow
% of AUM
17.86%
Top 10 Holdings %
Top 10 Hldgs %
58.82%
Holding
92
New
32
Increased
17
Reduced
11
Closed
30
Top Buys
| 1 |
Amgen
AMGN
|
$28.9M |
| 2 |
AbbVie
ABBV
|
$21.5M |
| 3 |
DexCom
DXCM
|
$20.1M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$19.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$15.6M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$25.5M |
| 2 |
Johnson & Johnson
JNJ
|
$21.1M |
| 3 |
Medtronic
MDT
|
$14.2M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$9.82M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$8.66M |
Sector Composition
| 1 | Healthcare | 92.91% |
| 2 | Industrials | 0.23% |
| 3 | Financials | 0.16% |
| 4 | Technology | 0.14% |
| 5 | Energy | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Prospect Capital
PSEC
$1.33B
| $169K | 0.05% |
+27,957
| New | +$169K |
|
52
Antero Midstream
AM
$8.65B
| $161K | 0.05% |
13,448
+1,773
| +15% | +$21.2K |
|
53
Editas Medicine
EDIT
$227M
| $151K | 0.05% |
19,295
-351,582
| -95% | -$2.74M |
|
54
RPC Inc
RES
$1.06B
| $108K | 0.03% |
+12,071
| New | +$108K |
|
55
Ironwood Pharmaceuticals
IRWD
$179M
| $99.4K | 0.03% |
+10,326
| New | +$99.4K |
|
56
Under Armour
UAA
$2.26B
| $88.4K | 0.03% |
+12,904
| New | +$88.4K |
|
|
SWN
57
DELISTED
Southwestern Energy Company
SWN
| $88.3K | 0.03% |
+13,693
| New | +$88.3K |
|
58
GCM Grosvenor
GCMG
$677M
| $79.4K | 0.03% |
+10,229
| New | +$79.4K |
|
59
Newmark Group
NMRK
$3.17B
| $73.4K | 0.02% |
+11,417
| New | +$73.4K |
|
60
JetBlue
JBLU
$1.85B
| $68.8K | 0.02% |
14,952
+1,061
| +8% | +$4.88K |
|
61
Dover
DOV
$24.5B
| – | – |
-1,512
| Closed | -$223K |
|
|
62
Johnson & Johnson
JNJ
$431B
| – | – |
-127,362
| Closed | -$21.1M |
|
63
Kinder Morgan
KMI
$59.4B
| – | – |
-10,324
| Closed | -$178K |
|
64
Kenvue
KVUE
$39.4B
| – | – |
0
| – | – |
|
65
Legend Biotech
LEGN
$6.46B
| – | – |
-116,768
| Closed | -$8.06M |
|
|
66
Eli Lilly
LLY
$666B
| – | – |
-54,369
| Closed | -$25.5M |
|
|
67
Medtronic
MDT
$119B
| – | – |
-160,660
| Closed | -$14.2M |
|
68
Mersana Therapeutics
MRSN
$35.5M
| – | – |
-17,132
| Closed | -$1.41M |
|
69
Merus
MRUS
$5.01B
| – | – |
-101,691
| Closed | -$2.68M |
|
70
Prudential Financial
PRU
$38.3B
| – | – |
-2,463
| Closed | -$217K |
|
71
Protagonist Therapeutics
PTGX
$3.71B
| – | – |
-33,750
| Closed | -$932K |
|
72
Rithm Capital
RITM
$6.66B
| – | – |
-13,531
| Closed | -$127K |
|
73
Roivant Sciences
ROIV
$8.58B
| – | – |
-202,406
| Closed | -$2.04M |
|
74
Stevanato
STVN
$6.29B
| – | – |
-176,359
| Closed | -$5.71M |
|
75
Under Armour Class C
UA
$2.19B
| – | – |
-11,603
| Closed | -$77.9K |
|